SERNOVA CORP. (PSH.BE)
- Simply Wall St.
Here's Why We're Not At All Concerned With Sernova's (CVE:SVA) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- GlobeNewswire
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”. REGISTER OR LOGIN AT: https://bit.ly/3tThRej March 25th Presenting Companies: Presenting CompanyTicker(s)MagicMed Industries Inc.Ticker PendingSernova Corp.OTCQB: SEOVF | TSX-V: SVAVolitionRx LimitedNYSE AMERICAN: VNRXSkylight Health Group Inc.OTCQX: SHGFF | TSX-V:SHGElse Nutrition Holdings Inc.OTCQX: BABYF | TSX-V: BABYCardiol Therapeutics Inc.OTCQX: CRTPF | TSX: CRDLEarthRenew Inc.OTCQB: VVIVF | CSE: ERTHAvicanna Inc.OTCQX: AVCNF | TSX: AVCNOrexo ABOTCQX: ORXOY | STO: ORXCloudMD Software & Services Inc.Pink: DOCRF | TSX-V: DOC To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com. About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors. A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. CONTACT: CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com
- GlobeNewswire
Sernova to Webcast Live at Life Sciences Investor Forum March 25th
Sernova invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comLONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics company, today announced that Dr. Philip Toleikis, President and CEO will present live at LifeSciencesInvestorForum.com on March 25th. DATE: Thursday, March 25thTIME: 10:30am ETLINK: https://bit.ly/3qVRFyI This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.lifesciencesinvestorforum.com. Recent Company Highlights Sernova is the first and only regenerative medicine therapeutics platform company to demonstrate a well- vascularized subcutaneous islet transplant technology achieving persistent islet graft function in diabetic patientsSernova has acquired all the patented technology and knowhow for a cellular local immune protection technology (Conformal Coating Technology)Sernova has recently completed a $23M bought deal, providing the company with a strong cash position About SernovaSernova Corp is developing regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells (i.e. human donor cells, corrected human cells, and stem cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases such as insulin-dependent diabetes, blood disorders including hemophilia, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. For more information, please visit www.sernova.com About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors. A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. CONTACT: CONTACTS: Sernova Corp Dominic Gray Head of Communications (519) 858-5126 dominic.gray@sernova.com www.sernova.com Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com
